Yamamoto Akio, Tanioka Eri, Maeda Mikio
Hyogo Prefectural Institute of Public Health and Environmental Sciences.
Kansenshogaku Zasshi. 2009 Mar;83(2):107-12. doi: 10.11150/kansenshogakuzasshi.83.107.
The National Epidemiological Surveillance of Infectious Diseases (NESID) estimates the number of influenza patients using sentinel medical institutions reports (NESID estimate) rather than the actual number of patients visiting medical institutions. We estimated Hyogo Prefecture influenza patient numbers using Oseltamivir consumption (Oseltamivir estimate) to determine NESID estimate validity for the Nov-May, 2003-2007 influenza seasons. We divided the seasonal Oseltamivir estimate by the NESID estimate to derive an estimated prescription rate assuming that the NESID estimate was accurate. Estimated prescription rates ranged from 50% to 100%, but the NESID estimate assumption is appropriate from the relationship between the estimated prescription rate and prescription status. In 2004-2005 and 2005-2006 years 94% and 100% for the estimated prescription rate were close to the results (90%) from nationwide Oseltamivir prescription investigation. Nationwide analysis and investigations needed in other seasons on prescription rate of influenza medicine (Oseltamivir, Zanamivir, etc.) are thus needed for generalization on the validity of "NESID estimate".
国家传染病流行病学监测(NESID)使用定点医疗机构报告来估算流感患者数量(NESID估算值),而非前往医疗机构就诊的实际患者数量。我们利用奥司他韦的消耗量来估算兵库县的流感患者数量(奥司他韦估算值),以确定NESID估算值在2003 - 2007年11月至次年5月流感季节的有效性。我们将季节性奥司他韦估算值除以NESID估算值,假设NESID估算值准确,从而得出估计的处方率。估计的处方率在50%至100%之间,但从估计的处方率与处方状况之间的关系来看,NESID估算值的假设是合适的。在2004 - 2005年和2005 - 2006年,估计的处方率分别为94%和100%,接近全国奥司他韦处方调查的结果(90%)。因此,需要在其他季节进行全国性分析和调查,以了解流感药物(奥司他韦、扎那米韦等)的处方率,从而推广“NESID估算值”的有效性。